Goal: Intensify Treatment for Heart Patients
Posted on: Tuesday, 16 May 2006, 06:04 CDT
By Steve Sternberg
Mounting evidence that scores of heart patients can avoid second heart attacks or strokes with intensive treatment to reduce their risks prompted the nation's two top heart organizations on Monday to jointly issue new prevention recommendations.
The two groups call for more routine use of high-potency statins to lower bad cholesterol (low-density lipoprotein or LDL). They recommend expanding the use of other drugs that lower blood pressure and ease the heart's workload. They also, for the first time, back seasonal flu shots for all chronic heart disease patients.
"That's a really important major new recommendation," says Sidney Smith, of the University of North Carolina-Chapel Hill, and chairman of the American Heart Association and American College of Cardiology group that issued the guidelines.
Because new studies also show that lower aspirin doses are just as effective for prevention as higher ones, the guidelines recommend dropping daily doses to between 75 milligrams a day and 162 milligrams, except in patients who have had bypass surgery. Bypass patients fare best on 100 to 300 milligrams a day for up to a year.
The so-called secondary prevention guidelines could affect as many as 26 million people in the USA who have survived heart attacks and strokes and those with chronic coronary heart disease, Smith says.
They don't address primary prevention, or what to do for people who don't yet have heart disease.
Multiple studies show that "aggressive, comprehensive risk-factor management" boosts survival, prevents second heart attacks and strokes, reduces the need for bypass surgery and balloon angioplasty and improves the quality of life for heart patients, the authors write.
"Thanks to the clinical trials, we have definitive proof on all these things, which we can't say for primary prevention," says Robert Califf, director of the Duke University Clinical Research Institute, who is not one of the authors but who is familiar with the guidelines.
Califf says primary prevention studies are far more difficult to carry out because they require tens of thousands of low-risk people and may take decades to yield clear results. For instance, he says, the Women's Health Initiative study failed to prove something that most people take for granted: that a low-fat diet helps healthy women prevent heart attacks and strokes.
"If you're 30 years old and your LDL cholesterol is a little high, common sense would tell you that it might be good to treat it (with medication), but we don't know, because the evidence isn't in," Califf says.
"If you're 70 years old, and you've got a high LDL and you've already had a heart attack, your risk of something bad happening is so high, aggressive treatment makes sense," he says. "We've got the proof."
(c) Copyright 2005 USA TODAY, a division of Gannett Co. Inc.
Source: USA TODAY
Related Articles
- Aspirin Appears To Help Lower Risk Of Stroke For Patients With Peripheral Artery Disease
- deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
- Whole-House Air Cleaner May Help Prevent Asthma Attack, Heart Attack and Stroke
- Newly Published Guidelines for Treatment of Heart Valve Disease Lower Recommended Age for Tissue Valve Recipients
- Pfizer's Lipitor Provides Greater Reductions in Heart Attack, Stroke and Cardiovascular Procedures at an Overall Cost Savings Compared to Zocor, New Analysis Shows
- Results of exercise test may predict death in patients with coronary artery disease
- MRI is Better Than SPECT in Assessing Heart Damage in Patients with Hypertrophic Cardiomyopathy
- Benefits Found in High Doses of Statins; Reducing Cholesterol in Heart Patients Lowers Risk of Heart Attacks, Strokes, 5-Year Study Shows
- Pfizer's Norvasc Demonstrates Significant Reductions in Major Cardiovascular Events in Patients With Coronary Artery Disease
- India Says It Prevented Terrorist Attack
User Comments (0)

RSS Feeds